SelectQuote, Inc. Form 8-K Summary
Business Context and Reporting Period
SelectQuote, Inc. reported its financial results for the first quarter ended September 30, 2023, in a Form 8-K dated November 2, 2023. The filing furnishes a related press release and investor presentation as Exhibits 99.1 and 99.2.
Financial Metrics
The filing text provided does not include the underlying financial results. Revenue, profit or loss, cash flow, margins, debt, liquidity, and other key metrics are not clearly stated and should be reviewed in Exhibits 99.1 and 99.2.
Material Changes Versus the Prior Comparable Period
The filing text does not provide quantitative or qualitative comparisons with the prior-year comparable quarter.
Guidance, Outlook, Risks, and Unusual Items
- The Company referenced notification to the New York Stock Exchange of its intent to cure a stock-price deficiency and any potential plans for doing so.
- Management cautioned that the Company’s ability to regain compliance with NYSE continued-listing standards within the applicable cure period is uncertain.
- Other risks include continued compliance with NYSE listing standards and the risk factors described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2023, and subsequent SEC filings.
- The exhibits were furnished under Item 2.02 and are not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference, except where expressly stated.
Investor Verification Items
- Review Exhibit 99.1 for first-quarter revenue, earnings, cash flow, operating metrics, and management commentary.
- Review Exhibit 99.2 for presentation-based trends, outlook, and any guidance.
- Verify the nature, cure period, and potential consequences of the NYSE stock-price deficiency.
- Assess liquidity, debt obligations, and operating risks using the quarter’s financial disclosures and the latest Form 10-Q.